What is Madrigal Pharmaceuticals, Inc.'s free cash flow?

Madrigal Pharmaceuticals, Inc. (MDGL) reported free cash flow of -$171.28M in Q1 2026.

How has Madrigal Pharmaceuticals, Inc.'s free cash flow changed year-over-year?

Madrigal Pharmaceuticals, Inc.'s free cash flow decreased by 92.7% year-over-year, from -$88.89M to -$171.28M.

What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s free cash flow?

Over 3 years (2021 to 2024), Madrigal Pharmaceuticals, Inc.'s free cash flow has grown at a 35.4% compound annual growth rate (CAGR), from -$184.13M to -$457.03M.

Madrigal Pharmaceuticals, Inc. MDGL Free cash flow

Free cash flow at other companies

Eli LillyLLY

$3.01B+1,828%

Arrowhead ResearchARWR

——

Other financials

Income statement

See full

Revenue$311.3M+127%

Gross profit$43.5M—

Operating income-$92.7M-16.9%

Net income-$94.4M-28.9%

EPS (diluted)-$3.25-24.5%

Balance sheet

See full

Cash & equivalents$232.2M+23.1%

Total debt$377.3M+187%

Total equity$543.5M-23.5%

Total assets$1.2B+23.1%

Cash flow

See full

Operating cash flow-$167.4M-88.4%

CapEx$3.8M—

Valuation

See full

Market cap$11.66B+64.2%

Enterprise value$11.81B+67.5%

P/S10.3×-12.1×

Profitability

See full

Gross margin96.5%—

Operating margin-27.7%-12.2pp

Net margin-27.3%-12.0pp

FCF margin-59.8%-29.6pp

Returns & leverage

See full

Return on equity-49.3%-0.8pp

Debt / equity0.7×+0.5×

Current ratio3.5×-2.4×

Where this comes from

Calculated from Madrigal Pharmaceuticals, Inc.’s reported figures.

−$167.4Mnet cash from operating−$3.8Mcapital expenditures=-$171.28M

The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Madrigal Pharmaceuticals, Inc.'s free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Madrigal Pharmaceuticals, Inc.'s free cash flow?: Madrigal Pharmaceuticals, Inc. (MDGL) reported free cash flow of -$171.28M in Q1 2026.
How has Madrigal Pharmaceuticals, Inc.'s free cash flow changed year-over-year?: Madrigal Pharmaceuticals, Inc.'s free cash flow decreased by 92.7% year-over-year, from -$88.89M to -$171.28M.
What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s free cash flow?: Over 3 years (2021 to 2024), Madrigal Pharmaceuticals, Inc.'s free cash flow has grown at a 35.4% compound annual growth rate (CAGR), from -$184.13M to -$457.03M.